HHS invests more than $560M to boost COVID-19 test supply

Listen
Text
  • Small
  • Medium
  • Large

HHS said Oct. 22 it has invested more than half a billion dollars to boost manufacturing of supplies needed to increase domestic COVID-19 testing. 

The agency awarded more than $562 million from the coronavirus rescue package to a dozen U.S. companies to support domestic manufacturing of supplies such as pipette tips, protective packaging, swabs and reagents used in COVID-19 testing. 

"Supporting manufacturing of needed products like these will help strengthen the supply chain for COVID-19 tests, including rapid at-home tests, with the goal of increasing supply and availability of tests that are high quality and easy to use," HHS said in a news release. 

Some of the investments include: 

  • $192.5 million awarded to Nalge Nunc International Corp., a subsidiary of Thermo Fisher Scientific, to increase domestic manufacturing of pipette tips.

  • $6.5 million awarded to US Cotton to increase domestic production capacity for polyester-tipped swabs used in COVID-19 home test kits and mass testing sites.
     
  • $14.7 million awarded to Steripack to boost domestic production of collection vials used for nasal swab tests. 

Read the full HHS news release here

 

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.